R. Sartori, E. Barbi, F. Poli, L. Ronfani, F. Marchetti, A. Amaddeo, A

Slides:



Advertisements
Similar presentations
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Advertisements

The prevalence of “risky behaviour” in adults with cystic fibrosis
Treatment compliance in children and adults with Cystic Fibrosis
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
William G. Flight, Jonathan Shaw, Susan Johnson, A
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis  Marco Zampoli, Komala Pillay, Henri Carrara,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of.
Cirrhosis and other liver disease in cystic fibrosis
John Widger, Sarath Ranganathan, Philip J. Robinson 
Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection  Marita Gilljam, Henrik Scherstén, Martin Silverborn, Bodil.
The ease of breathing test tracks clinical changes in cystic fibrosis
Controlled clinical trials in cystic fibrosis — are we doing better?
Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week- days during school term-time  Rosemary Ball, Kevin W. Southern, Pamela.
Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state  Bradley.
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Vitamin A and lung function in CF
Pulmonary nocardiosis in cystic fibrosis
A.H. Gifford  Journal of Cystic Fibrosis 
M. Wouthuyzen-Bakker, F.A.J.A. Bodewes, H.J. Verkade 
Demographics of glucose metabolism in cystic fibrosis
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
Cystic fibrosis related diabetes in an extremely young patient
Inhalation solutions — Which ones may be mixed
Physiologic endpoints for clinical studies for cystic fibrosis
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy  G. Fitch, K. Williams,
Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance  P. Goncalves-Vidigal,
Nasal polyposis in lung transplant recipients with cystic fibrosis
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Antine E. Stenbit, Wendy M. Bullington, Julie L. Heh, Patrick A. Flume 
Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients  E.B. Wilms, D.J. Touw, H.G.M. Heijerman 
Design and powering of cystic fibrosis clinical trials using rate of FEV1 decline as an efficacy endpoint  M.W. Konstan, J.S. Wagener, A. Yegin, S.J.
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis  Joseph M. Collaco, Karen S. Raraigh, Lawrence.
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis  M.N. Hurley, A.H. Amin Ariff, C. Bertenshaw,
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
James H. Hull, Rachel Garrod, Timothy B. Ho, Ronald K. Knight, John R
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis  Malena Cohen-Cymberknoh, Hannah Blau, David Shoseyov,
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Cystic fibrosis and pregnancy in the modern era: A case control study
Presentation transcript:

Respiratory training with a specific device in cystic fibrosis: A prospective study  R. Sartori, E. Barbi, F. Poli, L. Ronfani, F. Marchetti, A. Amaddeo, A. Ventura  Journal of Cystic Fibrosis  Volume 7, Issue 4, Pages 313-319 (July 2008) DOI: 10.1016/j.jcf.2007.12.003 Copyright © 2007 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Spiro Tiger. Description: Held unit with specific valve and respiratory pouch. Personal training target values are entered into the basic unit and serve to monitor the breathing frequency and depth during training. The display provides instruction such as “breathe faster” and a bar shows the respiration depth. The breathing frequency is paced by a moving light and brief sounds. In case of substantial deviation from the ideal training frequency, the Spiro Tiger ® issues optical and acoustic warnings. The data collected during a training session are passed by cable to the basic station where they are monitored and stored. Journal of Cystic Fibrosis 2008 7, 313-319DOI: (10.1016/j.jcf.2007.12.003) Copyright © 2007 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 Graphical representation of FEV1 values in patients with good compliance. Each number represents a patient. Journal of Cystic Fibrosis 2008 7, 313-319DOI: (10.1016/j.jcf.2007.12.003) Copyright © 2007 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 Graphical representation of FEV1 values in patients with low and no compliance. Each number represents a patient, the two patient with no adherence are represented in dotted lines. Journal of Cystic Fibrosis 2008 7, 313-319DOI: (10.1016/j.jcf.2007.12.003) Copyright © 2007 European Cystic Fibrosis Society Terms and Conditions